Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders?

Affiliations

Comment

R M Egeler et al. Med Pediatr Oncol. 2000 Oct.

. 2000 Oct;35(4):426-7.

doi: 10.1002/1096-911x(20001001)35:4<426::aid-mpo6>3.0.co;2-#.

¹ Universities of Calgary and Leiden, Pediatric Immuno-, Hemato-, Oncology and Bone Marrow Transplantation, Leiden, The Netherlands.

No abstract available

Comment in

Langerhans cell histiocytosis: a reactive or neoplastic disorder?
Zelger B. Zelger B. Med Pediatr Oncol. 2001 Dec;37(6):543-4. doi: 10.1002/mpo.1249. Med Pediatr Oncol. 2001. PMID: 11745894 No abstract available.
Langerhans cell histiocytosis: an identity crisis.
Favara BE. Favara BE. Med Pediatr Oncol. 2001 Dec;37(6):545. doi: 10.1002/mpo.1250. Med Pediatr Oncol. 2001. PMID: 11745895 No abstract available.
Oxidative stress, p53 expression, and the cytogenetic abnormalities in Langerhans cell histiocytosis.
Brown RE. Brown RE. Med Pediatr Oncol. 2002 Jan;38(1):70-1. doi: 10.1002/mpo.1271. Med Pediatr Oncol. 2002. PMID: 11835245 No abstract available.

Concurrent Langerhans cell histiocytosis and myelodysplasia in children.
Surico G, Muggeo P, Rigillo N, Gadner H. Surico G, et al. Med Pediatr Oncol. 2000 Oct;35(4):421-5. doi: 10.1002/1096-911x(20001001)35:4<421::aid-mpo5>3.0.co;2-h. Med Pediatr Oncol. 2000. PMID: 11025473